Credit Suisse Upgrades Mindray Medical (MR) to Outperform
Get Alerts MR Hot Sheet
Price: $5.36 --0%
Rating Summary:
6 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 19
Rating Summary:
6 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 19
Join SI Premium – FREE
Credit Suisse upgraded Mindray Medical (NYSE: MR) from Market Perform to Outperform, price target raised from $29 to $32.00.
For more ratings news on Mindray Medical click here and for the rating history of Mindray Medical click here.
Shares of Mindray Medical closed at $26.95 yesterday.
For more ratings news on Mindray Medical click here and for the rating history of Mindray Medical click here.
Shares of Mindray Medical closed at $26.95 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Deutsche Bank Upgrades PennyMac Mortgage Investment Trust (PMT) to Buy
- Rothschild Redburn Upgrades Apple (AAPL) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share